查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1859749

全球人工器官市場預測（至2032年）：按器官類型、通路、技術、最終用戶和地區分類的分析

Artificial Organs Market Forecasts to 2032 - Global Analysis By Organ Type (Artificial Heart, Artificial Eye, Artificial Kidney, Artificial Pancreas and Other Organ Types), Distribution Channel, Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 預測，全球人造器官市場規模預計在 2025 年達到 278 億美元，到 2032 年將達到 525 億美元，預測期內複合年成長率為 9.5%。

人工器官是指旨在替代或輔助受損或缺失的生物器官功能的人工裝置或組織。這些人工器官​​通常植入人體，以恢復血液過濾、氧氣輸送和荷爾蒙調節等重要功能。常見的例子包括人工心臟、人工腎臟、人工肺部和人工肝臟。這些人工器官​​採用高度生物相容性材料製成，以最大限度地減少排斥反應，並且通常會整合感測器和泵浦等先進技術。對於等待器官移植或合格器官捐贈條件的患者而言，人工器官是挽救生命的有效方案，在提高生存率和生活品質的同時，也有助於緩解全球器官捐贈短缺的問題。

慢性病增多

在全球範圍內，糖尿病、心血管疾病和腎衰竭等慢性疾病負擔日益加重，是推動人工器官市場發展的主要因素。由於這些疾病往往會導致器官衰竭，因此對人工器官的需求不斷成長。人口老化和生活方式相關的健康問題也進一步加劇了這一趨勢。對於等待器官移植時間漫長的患者而言，人工器官提供了一種挽救生命的選擇，使其成為現代醫療保健體系的重要組成部分，致力於提高患者的生存率和生活品質，從而推動了市場成長。

人工器官和移植手術高成本

儘管人工器官具有挽救生命的潛力，但其研發、製造和移植成本高昂，令許多人難以負擔。這些費用，加上術後護理和維護，限制了人工器官在低收入和中等收入社區的普及。保險覆蓋範圍的差異和嚴格的報銷政策進一步阻礙了市場成長。成本障礙影響醫療服務提供者和患者，儘管人工器官具有臨床益處，且在器官捐贈者短缺的情況下需求不斷成長，但成本問題仍然延緩了人工器官技術的廣泛應用。

技術進步

生物工程、機器人技術和材料科學的快速發展正在為人工器官市場創造新的機會。 3D列印、智慧感測器和生物相容性材料等技術創新正在提升人工器官的功能、耐久性和患者療效。這些技術能夠實現更精準的客製化和整合，降低排異反應率並提高性能。隨著研究的加速，人工器官正變得更加高效和普及，為醫療保健領域的廣泛應用打開了大門，並拓展了已開發經濟體和新興經濟體的市場潛力。

嚴格的監管核准流程

由於監管核准流程複雜且耗時，人工器官市場面臨許多挑戰。為確保安全性、有效性和生物相容性，需要進行大規模的臨床試驗並提交相關文件，這導致產品上市延遲並增加研發成本。美國食品藥物管理局（FDA）和歐洲藥品管理局（EMA）等監管機構制定了嚴格的標準，小規模製造商很難應付這些規定。這些障礙會減緩創新步伐並限制市場准入，尤其對於新興技術而言更是如此。

新冠疫情的影響：

新冠疫情擾亂了全球醫療衛生系統，影響了擇期手術，並延誤了器官移植。供應鏈中斷以及資源重新分配至疫情應對，減緩了人工器官的生產與分發。然而，這場危機也凸顯了建構具有韌性的醫療衛生基礎設施以及加速發展數位化和遠端監測技術的重要性。疫情後的復甦重新激發了需求，尤其是對維生設備的需求，這更加強調了在未來的醫療衛生規劃中，需要可擴展、可及的人工器官解決方案來滿足急性和慢性醫療需求。

預計在預測期內，醫院板塊將是最大的板塊。

由於醫院擁有先進的基礎設施、技術精湛的醫護人員以及進行複雜外科手術的能力，預計在預測期內，醫院領域將佔據最大的市場佔有率。這些機構是器官移植、術後照護和長期監測的主要中心。隨著慢性病住院患者數量的增加以及對專科部門投資的不斷成長，醫院仍然是進行人工器官移植的理想場所。醫院整合最尖端科技並遵守監管標準的能力進一步鞏固了市場地位。

預計在預測期內，人工腎臟細分市場將實現最高的複合年成長率。

由於末期腎臟病率不斷上升以及供腎數量有限，預計在預測期內，人工腎臟市場將呈現最高的成長率。穿戴式和植入式透析設備等技術創新正在改變患者照護，顯著提升患者的活動能力和生活品質。公眾意識的提高、有利的透析設備政策以及過濾和生物相容性方面的技術突破正在推動這些技術的普及應用。隨著全球腎臟疾病的持續成長，人工腎臟正成為腎臟健康領域的重要解決方案。

比最大的地區

在預測期內，亞太地區預計將佔據最大的市場佔有率，這主要得益於其龐大的人口基數、慢性病患病率的上升以及不斷完善的醫療基礎設施。中國、印度和日本等國家正大力投資醫療技術和器官替代療法。政府措施、醫療旅遊的興起以及人們對器官衰竭治療認知的提高，都推動了該地區的成長。主要製造商的存在以及有利的監管改革進一步鞏固了亞太地區在市場上的主導地位。

複合年成長率最高的地區：

由於北美擁有先進的醫療保健體系、強大的研發能力以及創新醫療技術的高普及率，預計該地區在預測期內將呈現最高的複合年成長率。該地區受益於完善的健保體系、高素質的專業人才和有利的法規環境。器官衰竭病例的增加以及對個人化、高效治療方案需求的成長正在推動市場擴張。生物技術公司與醫療服務提供者之間的策略合作也正在加速全部區域的產品開發和商業化進程。

免費客製化服務

訂閱本報告的用戶可享有以下免費客製化服務之一：

  • 公司簡介
    • 對至多三家其他市場公司進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
  • 競爭基準化分析
    • 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 原始研究資料
    • 次級研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球人工器官市場（依器官類型分類）

  • 人工心臟
  • 人工眼
  • 人工腎臟
  • 人工胰臟
  • 人工肺
  • 人工電子耳
  • 其他

6. 全球人工器官市場（依分銷管道分類）

  • 直銷
  • 經銷商
  • 線上銷售
  • 其他

7. 全球人工器官市場（依技術分類）

  • 機器
  • 電子機械混合
  • 生物
  • 生物相容性材料
  • 其他

8. 全球人工器官市場（依最終用戶分類）

  • 醫院
  • 研究所
  • 門診手術中心
  • 居家照護
  • 診所
  • 其他

9. 全球人工器官市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與併購
  • 新產品上市
  • 業務拓展
  • 其他關鍵策略

第11章 企業概況

  • Medtronic
  • Second Sight Medical Products
  • Abbott Laboratories
  • Ottobock
  • Boston Scientific
  • Ossur
  • Baxter
  • MED-EL
  • Abiomed
  • Getinge
  • Berlin Heart
  • Edwards Lifesciences
  • Cochlear
  • Ekso Bionics
  • CYBERDYNE
Product Code: SMRC31973

According to Stratistics MRC, the Global Artificial Organs Market is accounted for $27.8 billion in 2025 and is expected to reach $52.5 billion by 2032 growing at a CAGR of 9.5% during the forecast period. Artificial organs are engineered devices or tissues designed to replace or support the function of damaged or missing biological organs. These synthetic substitutes are typically implanted into the human body to restore vital functions such as blood filtration, oxygenation, or hormone regulation. Common examples include artificial hearts, kidneys, lungs, and livers. They are constructed using biocompatible materials to minimize rejection and often integrate advanced technologies like sensors or pumps. Artificial organs serve as life-saving solutions for patients awaiting transplants or those ineligible for donor organs, offering improved survival rates and quality of life while addressing the global shortage of organ donors.

Market Dynamics:

Driver:

Growing Prevalence of Chronic Diseases

The increasing global burden of chronic diseases such as diabetes, cardiovascular disorders, and kidney failure is a major driver of the artificial organs market. As these conditions often lead to organ dysfunction, the demand for artificial replacements continues to rise. Aging populations and lifestyle-related health issues further contribute to this trend. Artificial organs offer life-saving alternatives for patients who face long transplant wait times, making them essential in modern healthcare systems focused on improving survival and quality of life. Thus, it drives the growth of the market.

Restraint:

High Cost of Artificial Organs and Implantation Procedures

Despite their life-saving potential, artificial organs remain financially inaccessible for many due to high development, manufacturing, and surgical implantation costs. These expenses are compounded by post-operative care and maintenance, limiting adoption in low- and middle-income regions. Insurance coverage gaps and limited reimbursement policies further hinder market growth. The cost barrier affects both healthcare providers and patients, slowing widespread integration of artificial organ technologies despite their clinical benefits and growing demand in the face of organ donor shortages.

Opportunity:

Advancements in technology

Rapid advancements in bioengineering, robotics, and material science are creating new opportunities in the artificial organs market. Innovations such as 3D printing, smart sensors, and biocompatible materials are improving organ functionality, durability, and patient outcomes. These technologies enable more precise customization and integration, reducing rejection rates and enhancing performance. As research accelerates, artificial organs are becoming more efficient and accessible, opening doors for broader applications in healthcare and expanding the market's potential across both developed and emerging economies.

Threat:

Stringent Regulatory Approval Processes

The artificial organs market faces significant challenges due to complex and lengthy regulatory approval processes. Ensuring safety, efficacy, and biocompatibility requires extensive clinical trials and documentation, which delays product launches and increases development costs. Regulatory bodies such as the FDA and EMA impose rigorous standards, and navigating these frameworks can be difficult for smaller manufacturers. These hurdles may slow innovation and limit market entry, especially for novel technologies.

Covid-19 Impact:

The COVID-19 pandemic disrupted healthcare systems globally, affecting elective surgeries and delaying organ implantations. Supply chain interruptions and resource reallocation toward pandemic response slowed production and distribution of artificial organs. However, the crisis also highlighted the importance of resilient healthcare infrastructure and accelerated digital and remote monitoring technologies. Post-pandemic recovery has reignited demand, especially for life-supporting devices, and reinforced the need for scalable, accessible artificial organ solutions to address both emergency and chronic care needs in future healthcare planning.

The hospitals segment is expected to be the largest during the forecast period

The hospitals segment is expected to account for the largest market share during the forecast period, due to their advanced infrastructure, skilled personnel, and capacity to perform complex surgical procedures. These institutions serve as primary centers for organ implantation, post-operative care, and long-term monitoring. With rising patient admissions for chronic conditions and increased investment in specialized departments, hospitals remain the preferred setting for artificial organ deployment. Their ability to integrate cutting-edge technologies and comply with regulatory standards further strengthens their market.

The artificial kidney segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the artificial kidney segment is predicted to witness the highest growth rate, due to growing prevalence of end-stage renal disease and limited availability of donor kidneys. Innovations in wearable and implantable dialysis devices are transforming patient care, offering mobility and improved quality of life. Rising awareness, supportive reimbursement policies, and technological breakthroughs in filtration and biocompatibility are fueling adoption. As kidney-related disorders continue to rise globally, artificial kidneys are becoming a critical solution in renal healthcare.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to its vast population, rising incidence of chronic diseases, and expanding healthcare infrastructure. Countries like China, India, and Japan are investing heavily in medical technology and organ replacement therapies. Government initiatives, growing medical tourism, and increasing awareness about organ failure treatments contribute to regional growth. The presence of key manufacturers and favorable regulatory reforms further position Asia Pacific as a dominant force in the market.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced healthcare systems, strong R&D capabilities, and high adoption of innovative medical technologies. The region benefits from robust reimbursement frameworks, skilled professionals, and supportive regulatory environments. Rising cases of organ failure, coupled with growing demand for personalized and efficient treatment options, are fueling market expansion. Strategic collaborations between biotech firms and healthcare providers also accelerate product development and commercialization across the region.

Key players in the market

Some of the key players in Artificial Organs Market include Medtronic, Second Sight Medical Products, Abbott Laboratories, Ottobock, Boston Scientific, Ossur, Baxter, MED-EL, Abiomed, Getinge, Berlin Heart, Edwards Lifesciences, Cochlear, Ekso Bionics, and CYBERDYNE.

Key Developments:

In October 2025, Medtronic is teaming up with DASI Simulations to apply AI-driven predictive modeling and digital-twin technology to the field of transcatheter aortic valve replacement (TAVR). The collaboration aims to deliver device-agnostic, patient-specific treatment planning that enhances procedural precision, anticipates complications, and supports personalized outcomes in structural heart interventions.

In July 2025, Medtronic and Philips have entered a multi-year strategic partnership to broaden access to advanced patient-monitoring technology, integrating Medtronic's sensor expertise into Philips' monitoring systems. This collaboration aims to enhance global clinician tools, streamline procurement of ECG/NIBP supplies, and improve patient-care outcomes through validated, combined solutions.

Organ Types Covered:

  • Artificial Heart
  • Artificial Eye
  • Artificial Kidney
  • Artificial Pancreas
  • Artificial Lung
  • Cochlear Implants
  • Other Organ Types

Distribution Channels Covered:

  • Direct Sales
  • Distributors
  • Online Sales
  • Other Distribution Channels

Technologies Covered:

  • Mechanical
  • Electro-Mechanical Hybrid
  • Biological
  • Biocompatible Materials
  • Other Technologies

End Users Covered:

  • Hospitals
  • Research Institutions
  • Ambulatory Surgical Centers
  • Homecare
  • Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Artificial Organs Market, By Organ Type

  • 5.1 Introduction
  • 5.2 Artificial Heart
  • 5.3 Artificial Eye
  • 5.4 Artificial Kidney
  • 5.5 Artificial Pancreas
  • 5.6 Artificial Lung
  • 5.7 Cochlear Implants
  • 5.8 Other Organ Types

6 Global Artificial Organs Market, By Distribution Channel

  • 6.1 Introduction
  • 6.2 Direct Sales
  • 6.3 Distributors
  • 6.4 Online Sales
  • 6.5 Other Distribution Channels

7 Global Artificial Organs Market, By Technology

  • 7.1 Introduction
  • 7.2 Mechanical
  • 7.3 Electro-Mechanical Hybrid
  • 7.4 Biological
  • 7.5 Biocompatible Materials
  • 7.6 Other Technologies

8 Global Artificial Organs Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Research Institutions
  • 8.4 Ambulatory Surgical Centers
  • 8.5 Homecare
  • 8.6 Clinics
  • 8.7 Other End Users

9 Global Artificial Organs Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic
  • 11.2 Second Sight Medical Products
  • 11.3 Abbott Laboratories
  • 11.4 Ottobock
  • 11.5 Boston Scientific
  • 11.6 Ossur
  • 11.7 Baxter
  • 11.8 MED-EL
  • 11.9 Abiomed
  • 11.10 Getinge
  • 11.11 Berlin Heart
  • 11.12 Edwards Lifesciences
  • 11.13 Cochlear
  • 11.14 Ekso Bionics
  • 11.15 CYBERDYNE

List of Tables

  • Table 1 Global Artificial Organs Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Artificial Organs Market Outlook, By Organ Type (2024-2032) ($MN)
  • Table 3 Global Artificial Organs Market Outlook, By Artificial Heart (2024-2032) ($MN)
  • Table 4 Global Artificial Organs Market Outlook, By Artificial Eye (2024-2032) ($MN)
  • Table 5 Global Artificial Organs Market Outlook, By Artificial Kidney (2024-2032) ($MN)
  • Table 6 Global Artificial Organs Market Outlook, By Artificial Pancreas (2024-2032) ($MN)
  • Table 7 Global Artificial Organs Market Outlook, By Artificial Lung (2024-2032) ($MN)
  • Table 8 Global Artificial Organs Market Outlook, By Cochlear Implants (2024-2032) ($MN)
  • Table 9 Global Artificial Organs Market Outlook, By Other Organ Types (2024-2032) ($MN)
  • Table 10 Global Artificial Organs Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 11 Global Artificial Organs Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 12 Global Artificial Organs Market Outlook, By Distributors (2024-2032) ($MN)
  • Table 13 Global Artificial Organs Market Outlook, By Online Sales (2024-2032) ($MN)
  • Table 14 Global Artificial Organs Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 15 Global Artificial Organs Market Outlook, By Technology (2024-2032) ($MN)
  • Table 16 Global Artificial Organs Market Outlook, By Mechanical (2024-2032) ($MN)
  • Table 17 Global Artificial Organs Market Outlook, By Electro-Mechanical Hybrid (2024-2032) ($MN)
  • Table 18 Global Artificial Organs Market Outlook, By Biological (2024-2032) ($MN)
  • Table 19 Global Artificial Organs Market Outlook, By Biocompatible Materials (2024-2032) ($MN)
  • Table 20 Global Artificial Organs Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 21 Global Artificial Organs Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Artificial Organs Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 23 Global Artificial Organs Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 24 Global Artificial Organs Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 25 Global Artificial Organs Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 26 Global Artificial Organs Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 27 Global Artificial Organs Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.